Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
American Heart Journal|December 9, 2020
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) InvestigatorsAnthony P Carnicelli, Hwanhee Hong, Robert P Giugliano, et al.
The Journal of Invasive Cardiology|February 10, 2015
Prevalence and treatment of "balloon-uncrossable" coronary chronic total occlusionsSiddharth M Patel, Nagendra R Pokala, Rohan V Menon, et al.
JACC. Heart Failure|May 7, 2025
Rationale and Design of the Dapagliflozin Effect on Cardiovascular Events in Acute Heart Failure (DAPA ACT HF)-TIMI 68 TrialDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
The American Journal of Medicine|May 5, 2020
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action InitiativeEbrahim Barkoudah, Gregory Piazza, Todd E H Hecht, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Nature Medicine|August 6, 2024
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trialsNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
European Journal of Heart Failure|December 22, 2023
Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61Siddharth M Patel, David A Morrow, Andrea Bellavia, et al.
Circulation|December 28, 2018
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 TrialBenjamin M Scirica, Erin A Bohula, Jamie P Dwyer, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
Pageof 20